Telix Pharmaceuticals Limited (TLX)
NASDAQ: TLX · Real-Time Price · USD
7.52
+0.39 (5.47%)
At close: Mar 6, 2026, 4:00 PM EST
7.60
+0.08 (1.06%)
After-hours: Mar 6, 2026, 6:46 PM EST
Telix Pharmaceuticals Employees
As of December 31, 2025, Telix Pharmaceuticals had 1,184 total employees, including 1,120 full-time and 64 part-time employees. The number of employees increased by 950 or 405.98% compared to the previous year.
Employees
1,184
Change
950
Growth
405.98%
Revenue / Employee
$678,880
Profits / Employee
-$6,018
Market Cap
2.56B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 1,184 | 950 | 405.98% |
| Dec 31, 2022 | 234 | 76 | 48.10% |
| Dec 31, 2021 | 158 | 149 | 1,655.56% |
| Dec 31, 2017 | 9 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Apellis Pharmaceuticals | 739 |
| Adaptive Biotechnologies | 619 |
| Galapagos NV | 558 |
| Beam Therapeutics | 511 |
| Travere Therapeutics | 497 |
| Ocular Therapeutix | 325 |
| Wave Life Sciences | 317 |
| Dyne Therapeutics | 240 |
TLX News
- 2 days ago - Telix Pharmaceuticals Limited (TLX) Discusses Physician Perspectives on Innovations in PSMA PET CT Imaging for Prostate Cancer Transcript - Seeking Alpha
- 4 days ago - Telix Pharmaceuticals Ltd at TD Cowen Healthcare Conference Transcript - GuruFocus
- 5 days ago - Telix Pharmaceuticals: Scope Of Company Beyond Radio Antibody-Drug Conjugate TLX591-Tx - Seeking Alpha
- 8 days ago - Telix Joins Forces with University Hospital Essen on PROMISE-PET: Optimizing Patient Management through AI-enabled PSMA-PET Imaging - GlobeNewsWire
- 9 days ago - 1 Basically Unknown Stock That Could Turn Cancer‑Imaging Breakthroughs Into Generational Wealth - The Motley Fool
- 11 days ago - Citigroup Raises Price Target on Telix Pharmaceuticals (TLX) to $22.50 | TLX Stock News - GuruFocus
- 15 days ago - Telix Pharmaceuticals Limited (TLX) Q4 2025 Earnings Call Transcript - Seeking Alpha
- 15 days ago - Telix Pharmaceuticals Ltd (TLPPF) Full Year 2025 Earnings Call Highlights: Robust Revenue ... - GuruFocus